Company intelligence
Access to Medicine Foundation
Moving pharmaceutical companies to expand access to their products in low- & middle-income countries
About Access to Medicine Foundation
The Access to Medicine Foundation is an independent non-profit organisation based in the Netherlands. We seek to transform the healthcare ecosystem by motivating and mobilising companies to expand access to their essential healthcare products in low- and middle-income countries. Over the past two decades, we have demonstrated the power of data, collaboration and persuasion to trigger action by the pharmaceutical industry and scale up access to products. Our tried-and-tested approach involves defining the actions that healthcare companies should take, analysing what companies are actually doing, and promoting best practices. To turn our insights into action, we engage with the companies we evaluate, as well as with stakeholders across the private and public sectors. Our power to make an impact has been proven in the case of Big Pharma, as demonstrated by the success of the Access to Medicine Index. We have now begun to further expand our scope and use our change-making model to move companies across a wider range of healthcare sectors. This encompasses core groups of companies across five sectors: Big Pharma, vaccine manufacturers, generic medicine manufacturers, diagnostic companies and medical gas companies. Learn more about how we are taking access to the next level 👉 accesstomedicinefoundation.org/news/taking-access-to-the-next-level-mobilising-five-essential-healthcare-sectors
Verified activity
Signals from Access to Medicine Foundation
7 published signals
Research & Knowledge
Access to Medicine Foundation published a new report examining eight generic and biosimilar medicine manufacturers operating across Africa and their responses to evolving healthcare needs and access challenges.
Reported by Access to Medicine Foundation
Research & Knowledge
Access to Medicine Foundation launched its Generic & Biosimilar Medicine report highlighting trends and opportunities for securing local availability of medicines.
Reported by Jayasree Iyer
Presence & Recognition
Access to Medicine Foundation hosted a meeting in March bringing together leaders from multinational and regional African generic and biosimilar medicine manufacturers alongside implementation partners to discuss practical ways to strengthen the supply and availability of quality-assured medicines across the continent.
Reported by Access to Medicine Foundation
Research & Knowledge
Access to Medicine Foundation CEO Jayasree Iyer published an op-ed for Devex examining what shrinking foreign aid means for Africa's health systems and long-term resilience.
Reported by Access to Medicine Foundation
Research & Knowledge
Access to Medicine Foundation is publishing a new report on generic and biosimilar medicines, coming out soon.
Reported by Access to Medicine Foundation
Research & Knowledge
Access to Medicine Foundation runs the Generic & Biosimilar Medicines Programme to analyze company action and engage manufacturers on expanding access to generic and biosimilar medicines.
Reported by Access to Medicine Foundation
Presence & Recognition
Access to Medicine Foundation is attending the UNGA81 event in New York later this September with Pauline L'Hénaff and Margo Warren.
Reported by Jayasree Iyer